Patents Assigned to Beth Israel Deaconess Medical Center , Inc. And Trustees of Boston University
  • Publication number: 20100168160
    Abstract: Genipin derivatives and pharmaceutical compositions thereof that inhibit the activity of uncoupling protein-2 (UCP2) and are useful in treating deficient first-phase insulin secretion, non-insulin dependent diabetes mellitus, and ischemia in a mammal are disclosed.
    Type: Application
    Filed: November 19, 2009
    Publication date: July 1, 2010
    Applicant: Beth Israel Deaconess Medical Center , Inc. And Trustees of Boston University
    Inventors: Chen-Yu Zhang, Bradford B. Lowell, John A. Porco, JR., Ruichao Shen, Cheng T. Lin, Stefan Krauss